07/19/2021 | Press release | Distributed by Public on 07/19/2021 07:41
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
Description of the financial instrument, type of instrument
|
Smith & Nephew plc SPON ADR American Depositary Shares (ADS)
|
Identification code
|
ISIN: US83175M2052
|
Nature of the transaction
|
Purchase of American Depository Shares as participants of the Company's Employee Stock Purchase Plan.
|
Date of Transaction
|
2021 - 07 - 13
|
Place of Transaction
|
New York Stock Exchange
|
Name
|
Director / PDMR
|
Price ($)
|
Volume
|
Aggregated information
|
Total Ordinary Share Holding following the transaction *
|
Total Ordinary Share Holding as a % of the Company's ISC following the transaction *
|
Bradley Cannon
(President Sports Medicine & ENT)
|
PDMR
|
36.52
|
290.9006
|
N/A Single Transaction
|
77,921.38984 (including 2,414.63870 in ADS')
|
0.00880%
|
Catheryn O'Rourke
(Chief Legal & Compliance Officer)
|
PDMR
|
36.52
|
290.9006
|
N/A Single Transaction
|
82,804.67869 (including 6,170.31995 in ADS')
|
0.00936%
|